AI Verdict
HIPOW has stronger fundamentals based on our AI analysis.
HIT vs HIPOW Fundamental Comparison
| Metric | HIT | HIPOW |
|---|---|---|
| Revenue | $33.3M | $468.6M |
| Net Income | $1.3M | $57.7M |
| Net Margin | 3.8% | 12.3% |
| ROE | 7.5% | 13.2% |
| ROA | 5.5% | 3.0% |
| Current Ratio | 3.13x | 0.69x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $0.02 | $2.22 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HIT vs HIPOW: Frequently Asked Questions
Is HIT or HIPOW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HIPOW has stronger fundamentals. HIT is rated SELL (72% confidence) while HIPOW is rated HOLD (48% confidence). This is not investment advice.
How does HIT compare to HIPOW fundamentally?
Health In Tech, Inc. has ROE of 7.5% vs Hippo Holdings Inc.'s 13.2%. Net margins are 3.8% vs 12.3% respectively.
Which stock pays higher dividends, HIT or HIPOW?
HIT has a dividend yield of N/A or no dividend while HIPOW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HIT or HIPOW for long term?
For long-term investing, consider that HIT has SELL rating with 72% confidence, while HIPOW has HOLD rating with 48% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HIT vs HIPOW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HIT vs HIPOW, the AI consensus favors HIPOW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.